Larimar Therapeutics, Inc.

LRMR · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.5B · 71 employees
237
SEC Filings
$2.73
Close 2026-11-11
71
Employees

Business Summary

Larimar Therapeutics is a clinical-stage biotechnology company developing treatments for rare diseases using its cell penetrating peptide (CPP) technology platform. Its lead product candidate, nomlabofusp, is a subcutaneously administered recombinant fusion protein designed to deliver frataxin (FXN) to mitochondria in patients with Friedreich's ataxia (FA), a rare progressive fatal disease. The company holds multiple FDA designations including Breakthrough Therapy, Fast Track, Orphan Drug, and Pediatric Rare Disease Designations.

Latest Stock Quote

LRMR 2026-11-11 $2.73 O:$2.72 H:$2.83 L:$2.6 Vol:1.2M VWAP:$2.735
origin leaf: null

Next Earnings

expected 2026-12-29

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-192025-12-310001193125-26-115878EDGAR90K words
2025-03-242024-12-310000950170-25-043925EDGAR87K words
2024-03-142023-12-310000950170-24-031529EDGAR83K words
2023-03-142022-12-310000950170-23-007855EDGAR78K words
2022-03-252021-12-310000950170-22-004637EDGAR77K words
2021-03-042020-12-310001564590-21-011003EDGAR71K words
2020-03-052019-12-310001564590-20-008984EDGAR71K words
2019-03-142018-12-310001564590-19-007863EDGAR74K words
2018-03-092017-12-310001193125-18-077456EDGAR77K words
2017-03-102016-12-310001193125-17-078784EDGAR74K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-162026-09-300001193125-26-462242EDGAR—
2026-08-042026-06-300001193125-26-331529EDGAR22K words
2025-11-052025-09-300001193125-25-266969EDGAR23K words
2025-08-142025-06-300000950170-25-108797EDGAR23K words
2025-04-302025-03-310000950170-25-061222EDGAR22K words
2024-10-302024-09-300000950170-24-119100EDGAR22K words
2024-08-082024-06-300000950170-24-093733EDGAR21K words
2024-05-092024-03-310000950170-24-056965EDGAR19K words
2023-11-142023-09-300000950170-23-063517EDGAR21K words
2023-08-102023-06-300000950170-23-041293EDGAR20K words
2023-05-152023-03-310000950170-23-022187EDGAR18K words
2022-11-102022-09-300000950170-22-024223EDGAR20K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-160001193125-26-462054EDGAR—
2026-11-090001193125-26-453586EDGAR5K words
2026-09-290001193125-26-407331EDGAR2K words
2026-08-040001193125-26-331516EDGAR3K words
2026-03-190001193125-26-115119EDGAR3K words
2026-03-090001193125-26-098493EDGAR7K words
2026-02-270001193125-26-077646EDGAR26K words
2026-02-240001193125-26-065186EDGAR7K words
2026-01-220001193125-26-018664EDGAR10K words
2026-01-120001193125-26-010409EDGAR7K words

237 total filings indexed. 205 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

rare-diseases orphan-diseases neurodegenerative-diseases friedreich's-ataxia cell-penetrating-peptide-(cpp)-technology lyophilized-drug-product-formulation subcutaneous-drug-delivery recombinant-fusion-protein-technology

Company Identity

CIK0001374690
TickerLRMR
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.larimartx.com
Listed2020-05-29

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 5e09cbcc2313dc43fc09b46362f150e95b670715f0429d34f5c9fe8b4d73405b
parent: 4771a323306b83c2ff4d911eddb82d4b28f708d9ae2b63890e8d0e13702c47e6
content hash: 71db0006a2407f08efa922c1fde85b9077d6c73b7a6d020ee6497d272bb2c65a
signed: 2026-11-16T19:03:20.999Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up LRMR using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on LRMR, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/LRMR (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.